BioCurex strengthens leadership
This article was originally published in Clinica
Canadian cancer diagnostics company BioCurex has strengthened its leadership team by appointing Dr Paul Slowey and Mr Trent Davis to its board of directors. Dr Slowey has also joined the company as president with responsibilities in marketing and management of OncoPet diagnostics. He was CEO of BioCurex 2001-2002 and recently was president and CEO of Oasis Diagnostics. Mr Davis is currently president and CEO of Paulson Investment Company.